Beam Therapeutics IncNASDAQ:BEAM
- LAST PRICE25.2900
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots24.0000/ 1
- Ask / Lots25.8900/ 2
- Open / Previous Close--- / 25.2900
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BEAM |
|---|---|---|
| 09:32 ET | 7475 | 23.98 |
| 09:35 ET | 3291 | 23.99 |
| 09:37 ET | 5418 | 23.875 |
| 09:39 ET | 6132 | 23.95 |
| 09:42 ET | 1001 | 24.08 |
| 09:44 ET | 5310 | 23.975533 |
| 09:46 ET | 614 | 23.99 |
| 09:48 ET | 3311 | 23.98 |
| 09:50 ET | 11812 | 23.99 |
| 09:51 ET | 806 | 24 |
| 09:53 ET | 1600 | 24.04 |
| 09:55 ET | 2405 | 24.04 |
| 09:57 ET | 800 | 23.985 |
| 10:00 ET | 4320 | 24.075 |
| 10:02 ET | 3107 | 23.79 |
| 10:04 ET | 500 | 23.82 |
| 10:06 ET | 712 | 23.885 |
| 10:08 ET | 644 | 23.825 |
| 10:09 ET | 600 | 24 |
| 10:11 ET | 450 | 24.15 |
| 10:13 ET | 1565 | 24.24 |
| 10:15 ET | 2655 | 24.25 |
| 10:18 ET | 4030 | 24.33 |
| 10:20 ET | 19434 | 24.4 |
| 10:22 ET | 4741 | 24.4 |
| 10:24 ET | 13830 | 24.4042 |
| 10:26 ET | 1100 | 24.49 |
| 10:27 ET | 100 | 24.515 |
| 10:29 ET | 700 | 24.51 |
| 10:31 ET | 700 | 24.41 |
| 10:33 ET | 600 | 24.475 |
| 10:36 ET | 300 | 24.485 |
| 10:38 ET | 576 | 24.53 |
| 10:40 ET | 100 | 24.525 |
| 10:42 ET | 700 | 24.4 |
| 10:44 ET | 508 | 24.44 |
| 10:45 ET | 200 | 24.4208 |
| 10:47 ET | 17050 | 24.36 |
| 10:49 ET | 2104 | 24.36 |
| 10:51 ET | 700 | 24.375 |
| 10:54 ET | 400 | 24.43 |
| 10:56 ET | 600 | 24.41 |
| 10:58 ET | 600 | 24.43 |
| 11:00 ET | 500 | 24.49 |
| 11:02 ET | 800 | 24.495 |
| 11:03 ET | 2322 | 24.4 |
| 11:05 ET | 1500 | 24.51 |
| 11:07 ET | 1700 | 24.49 |
| 11:09 ET | 400 | 24.5 |
| 11:12 ET | 825 | 24.47 |
| 11:14 ET | 2272 | 24.41 |
| 11:16 ET | 1564 | 24.495 |
| 11:18 ET | 567 | 24.5 |
| 11:20 ET | 562 | 24.627798 |
| 11:21 ET | 2200 | 24.585 |
| 11:23 ET | 100 | 24.55 |
| 11:25 ET | 978 | 24.58 |
| 11:27 ET | 600 | 24.61 |
| 11:30 ET | 200 | 24.61 |
| 11:32 ET | 749 | 24.64 |
| 11:34 ET | 873 | 24.71 |
| 11:36 ET | 581 | 24.675 |
| 11:38 ET | 1200 | 24.75 |
| 11:39 ET | 300 | 24.74 |
| 11:41 ET | 300 | 24.77 |
| 11:43 ET | 1066 | 24.69 |
| 11:45 ET | 840 | 24.6495 |
| 11:48 ET | 302 | 24.6093 |
| 11:50 ET | 100 | 24.58 |
| 11:52 ET | 500 | 24.55 |
| 11:54 ET | 1400 | 24.555 |
| 11:56 ET | 400 | 24.54 |
| 11:57 ET | 846 | 24.57 |
| 11:59 ET | 2721 | 24.59 |
| 12:01 ET | 500 | 24.56 |
| 12:03 ET | 300 | 24.53 |
| 12:06 ET | 827 | 24.54 |
| 12:08 ET | 1121 | 24.565 |
| 12:12 ET | 2283 | 24.685 |
| 12:14 ET | 100 | 24.675 |
| 12:15 ET | 721 | 24.65 |
| 12:17 ET | 5300 | 24.66 |
| 12:19 ET | 200 | 24.64 |
| 12:21 ET | 400 | 24.58 |
| 12:24 ET | 1500 | 24.53 |
| 12:26 ET | 600 | 24.53 |
| 12:28 ET | 1000 | 24.63 |
| 12:30 ET | 100 | 24.69 |
| 12:32 ET | 300 | 24.74 |
| 12:33 ET | 200 | 24.73 |
| 12:35 ET | 500 | 24.72 |
| 12:37 ET | 502 | 24.695 |
| 12:39 ET | 300 | 24.62 |
| 12:42 ET | 960 | 24.72 |
| 12:44 ET | 1946 | 24.71 |
| 12:46 ET | 500 | 24.715 |
| 12:48 ET | 3737 | 24.74 |
| 12:50 ET | 400 | 24.72 |
| 12:51 ET | 900 | 24.72 |
| 12:53 ET | 1439 | 24.73 |
| 12:55 ET | 5526 | 24.69 |
| 12:57 ET | 700 | 24.69 |
| 01:00 ET | 766 | 24.6923 |
| 01:02 ET | 2541 | 24.675 |
| 01:04 ET | 600 | 24.67 |
| 01:06 ET | 400 | 24.645 |
| 01:08 ET | 400 | 24.63 |
| 01:09 ET | 659 | 24.65 |
| 01:11 ET | 909 | 24.73 |
| 01:13 ET | 2000 | 24.72 |
| 01:15 ET | 200 | 24.74 |
| 01:18 ET | 300 | 24.735 |
| 01:20 ET | 300 | 24.7 |
| 01:22 ET | 2054 | 24.695 |
| 01:24 ET | 3300 | 24.73 |
| 01:26 ET | 701 | 24.69 |
| 01:27 ET | 400 | 24.72 |
| 01:29 ET | 1100 | 24.695 |
| 01:31 ET | 600 | 24.725 |
| 01:33 ET | 600 | 24.69 |
| 01:36 ET | 274 | 24.71 |
| 01:38 ET | 700 | 24.77 |
| 01:40 ET | 300 | 24.76 |
| 01:42 ET | 2900 | 24.69 |
| 01:44 ET | 2242 | 24.58 |
| 01:45 ET | 900 | 24.63 |
| 01:47 ET | 700 | 24.7 |
| 01:49 ET | 2054 | 24.74 |
| 01:51 ET | 1432 | 24.73 |
| 01:54 ET | 1846 | 24.755 |
| 01:56 ET | 3089 | 24.79 |
| 01:58 ET | 6242 | 24.765 |
| 02:00 ET | 1515 | 24.795 |
| 02:02 ET | 2382 | 24.76 |
| 02:03 ET | 3265 | 24.715 |
| 02:05 ET | 600 | 24.725 |
| 02:07 ET | 813 | 24.72 |
| 02:09 ET | 100 | 24.7 |
| 02:12 ET | 500 | 24.715 |
| 02:14 ET | 1305 | 24.75 |
| 02:16 ET | 500 | 24.72 |
| 02:18 ET | 2340 | 24.685 |
| 02:20 ET | 1400 | 24.68 |
| 02:21 ET | 1225 | 24.7 |
| 02:23 ET | 1400 | 24.73 |
| 02:25 ET | 2000 | 24.73 |
| 02:27 ET | 800 | 24.725 |
| 02:30 ET | 1000 | 24.73 |
| 02:32 ET | 5848 | 24.755 |
| 02:34 ET | 1183 | 24.755 |
| 02:36 ET | 800 | 24.75 |
| 02:38 ET | 1719 | 24.76 |
| 02:39 ET | 3200 | 24.725 |
| 02:41 ET | 1461 | 24.795 |
| 02:43 ET | 4432 | 24.845 |
| 02:45 ET | 500 | 24.93 |
| 02:48 ET | 4699 | 24.905 |
| 02:50 ET | 1224 | 24.84 |
| 02:52 ET | 738 | 24.89 |
| 02:54 ET | 100 | 24.875 |
| 02:56 ET | 3356 | 24.9694 |
| 02:57 ET | 1453 | 24.95 |
| 02:59 ET | 3747 | 24.91 |
| 03:01 ET | 4467 | 24.88 |
| 03:03 ET | 5232 | 24.9 |
| 03:06 ET | 4060 | 24.98 |
| 03:08 ET | 1861 | 25.06 |
| 03:10 ET | 500 | 25.11 |
| 03:12 ET | 2000 | 25.105 |
| 03:14 ET | 1270 | 25.12 |
| 03:15 ET | 5306 | 25.08 |
| 03:17 ET | 900 | 25.065 |
| 03:19 ET | 1915 | 25.08 |
| 03:21 ET | 1537 | 25.1 |
| 03:24 ET | 1400 | 25.12 |
| 03:26 ET | 1300 | 25.085 |
| 03:28 ET | 500 | 25.095 |
| 03:30 ET | 1970 | 25.13 |
| 03:32 ET | 607 | 25.09 |
| 03:33 ET | 2261 | 25.11 |
| 03:35 ET | 300 | 25.1 |
| 03:37 ET | 700 | 25.105 |
| 03:39 ET | 4279 | 25.11 |
| 03:42 ET | 6931 | 25.02 |
| 03:44 ET | 768 | 25.0314 |
| 03:46 ET | 2735 | 25.15 |
| 03:48 ET | 1055 | 25.21 |
| 03:50 ET | 3162 | 25.27 |
| 03:51 ET | 8752 | 25.145 |
| 03:53 ET | 6813 | 25.1525 |
| 03:55 ET | 9459 | 25.22 |
| 03:57 ET | 10799 | 25.32 |
| 04:00 ET | 514362 | 25.29 |
Nov 12, 2024
Beam Therapeutics to Participate in 2024 Jefferies London Healthcare Conference, from 4:01PM ET on Tuesday Nov 12, 2024 by Dow Jones
4:01PM ET on Tuesday Nov 12, 2024 by Dow Jones
Nov 7, 2024
DJ Beam Therapeutics Price Target Maintained With a $80.00/Share by HC Wainwright & Co., from 5:01AM ET on Thursday Nov 07, 2024 by Dow Jones
5:01AM ET on Thursday Nov 07, 2024 by Dow Jones
Nov 6, 2024
DJ Beam Therapeutics Is Maintained at Sector Perform by RBC Capital, from 11:10AM ET on Wednesday Nov 06, 2024 by Dow Jones
11:10AM ET on Wednesday Nov 06, 2024 by Dow JonesDJ Beam Therapeutics Raised to Outperform From Market Perform by Leerink Partners, from 7:39AM ET on Wednesday Nov 06, 2024 by Dow Jones
7:39AM ET on Wednesday Nov 06, 2024 by Dow Jones
Nov 5, 2024
Beam Therapeutics to Present Data Across Hematology Franchise, Including First Clinical Data for BEAM-101 in Sickle Cell Disease and ESCAPE Non-human Primate Data, at American Society of Hematology (ASH) Annual Meeting, from 9:00AM ET on Tuesday Nov 05, 2024 by Dow Jones
9:00AM ET on Tuesday Nov 05, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Beam Therapeutics Inc | 2.1B | -14.7x | --- |
Genmab A/S | 13.6B | 20.2x | +22.71% |
Galapagos NV | 1.8B | -27.7x | --- |
Catalyst Pharmaceuticals Inc | 2.6B | 18.2x | --- |
Twist Bioscience Corp | 2.4B | -11.5x | --- |
BioCryst Pharmaceuticals Inc | 1.5B | -11.9x | --- |
Company Information
Beam Therapeutics Inc. is a biotechnology company developing precision genetic medicines through base editing. The Company's suite of gene editing technologies is anchored by base editing, a technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the deoxyribonucleic acid. Its lead programs are focused on sickle cell disease and alpha-1 antitrypsin deficiency, and it is also advancing programs in other genetic diseases, as well as immunology/oncology. Its primary programs include BEAM-101, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-302, BEAM-301 and BEAM-201. BEAM-101 is a patient-specific, autologous hematopoietic stem cell (HSC), investigational therapy. ESCAPE is a potentially non-genotoxic approach to HSC transplantation. BEAM-302 is a liver-targeting lipid nanoparticle formulation of base editing reagents. BEAM-201 is an anti-CD7 CAR-T product candidate.
Contact Information
- Headquarters
- 238 Main StreetCAMBRIDGE, MA, United States 02142
- Phone
- 857-327-8775
- Fax
- 302-655-5049
Executives
- President
- Giuseppe Ciaramella
- Chief Executive Officer, Principal Financial and Accounting Officer, Director
- John Evans
- Chief Medical Officer
- Amy Simon
- Chief Legal Officer and Secretary
- Christine Bellon
- Lead Independent Director
- Mark Fishman
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.1B |
|---|---|
Revenue (TTM) | $349.6M |
Shares Outstanding | 82.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.87 |
EPS | $-1.72 |
Book Value | $12.02 |
P/E Ratio | -14.7x |
Price/Sales (TTM) | 6.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -52.25% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
